However, NRF3 overexpression barely influenced 26S proteasome activity in fractions 13 to 15 (Fig. 1D, bottom left and bottom middle), suggesting that NRF3 is a potent regulator of the 20S proteasome in cancer cells. The gene discussed is NFE2L3; the disease is cancer.